Cartillage matrix protein and methods for use
CA 2117780 A1 · Owner: The General Hospital Corporation · Inventors: Tondravi, Mehrdad; Goetinck, Paul F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
In general the invention features a substantially pure polypeptide which is a fragment or analog of cartilage matrix protein the, polypeptide being capable of binding collagen. In various preferred embodiments the polypeptide includes CMP-1 or CMP-2; the polypeptide is all or part of CMP-1; the polypeptide is all or part of CMP-2; and the polypeptide is all or part of CMP-1 and CMP-2. In a related aspect the invention features a method for forming collagen fibrils. The method includes contacting cartilage matrix protein with collagen. In another related aspect the invention, features a method for delivering a compound to collagenous tissue the method includes administering to a patient the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 2, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 2, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 2, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.